Persistent Candida parapsilosis funguria associated with an indwelling urinary tract stent for more than 7 years.

Abstract

Candiduria is an increasingly common condition, and the lack of effective antifungal treatment in many cases has raised great concern. We report a case of persistent Candida parapsilosis funguria associated with urinary tract instrumentation. Molecular typing suggested that during a 7 year period the C. parapsilosis isolates were all the same strain. Prolonged antifungal therapy and regular catheter replacement failed to eradicate the funguria, but improved urinary symptoms and pyuria. The antifungal susceptibility pattern did not significantly change during the clinical course despite repeated exposure to fluconazole.

• Authors: Sheng-Yuan Ruan, Jung-Yien Chien, Po-Ren Hsueh
• Journal: Journal of medical microbiology (J Med Microbiol) Vol. 57 Issue Pt 12 Pg. 1585-1587 (Dec 2008) ISSN: 0022-2615 [Print] England
• PMID: 19018034 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antifungal Agents
• Fluconazole

Topics

• Antifungal Agents (pharmacology, therapeutic use)
• Candida (classification, drug effects, genetics, isolation & purification)
• Candidiasis (drug therapy, microbiology)
• Fluconazole (pharmacology, therapeutic use)
• Humans
• Male
• Microbial Sensitivity Tests
• Middle Aged
• Time Factors
• Urinary Catheterization (adverse effects)
• Urinary Tract Infections (drug therapy, microbiology)
• Urine (microbiology)